A Multicentered Study on Efficiency of Noninvasive Ventilation Procedures — SAFE-NIV  

High Flow Nasal Cannula Clinical Trial

Official title: A Multicentered Study on Efficiency of Noninvasive Ventilation Procedures

Status Completed

Clinical Trial Summary

Noninvasive ventilation (NIV) is an alternative form of ventilatory support in critical care encompassing different modes of ventilation such as continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP) and high flow nasal cannula ventilation. Although numerous studies on adults exit in literature, the aspects of this ventilatory support is limited in pediatric age groups. Early recognition of respiratory failure and initiation of NIV in a pediatric patient would positively affect prognosis by avoiding certain complications of endotracheal intubation and mechanical ventilation and adds certain advantages. Decreasing re-intubation rates for the ones who are extubated but necessitating further oxygen support is another advantage of NIV. Although numerous studies on adults exit in literature, the aspects of this ventilatory support is limited in pediatric age groups. Besides, success as well as failure and complication rates in pediatric age groups vary extensively. This multi-centered, prospective cohort study is planned to observe the epidemiologic perspectives of study group within underlying problems, success rates between different age groups, complication and re-intubation rates and finally its' effect on prognosis and long term survival in a year period. Hence we believe results of this study would allow us to improve our knowledge on using this technique, applying different modes and parameters appropriately and design criteria to guide clinician in deciding which group of patients would benefit from NIV techniques.

Clinical Trial Description

Total of 9 pediatric critical care centers all across the country will collaborate at this study:

1. Akdeniz University Faculty of Medicine, Pediatric Critical Care Division

2. Cukurova University Faculty of Medicine, Pediatric Critical Care Division

3. Ege University Faculty of Medicine, Pediatric Critical Care Division

4. Ankara University Faculty of Medicine, Pediatric Critical Care Division

5. Ondokuz Mayis University Faculty of Medicine, Pediatric Critical Care Division

6. Erciyes University Faculty of Medicine, Pediatric Critical Care Division

7. Koc University Faculty of Medicine, Pediatric Critical Care Division

8. Dokuz Eylül University Faculty of Medicine, Pediatric Critical Care Division

9. Izmir Katip Celebi University Faculty of Medicine, Pediatric Critical Care Division Since nature of this study is an observational cohort, all noninvasively ventilated children from one month to eighteen years will be enrolled in this study. A three-page questionnaire is designed to collect data. The first page includes information on epidemiological data, underlying disease in terms of both acute and chronicle problems resulting in respiratory problems; the second page includes a multi-colon table to record vital signs (heart and respiratory rate, systemic and diastolic blood pressure), PRISM-III and Pediatric logistic organ dysfunction (PELOD) scores, Glasgow coma scale, blood gas values, ventilation parameters, necessity of sedation (if so, drugs used for sedation) and finally comfort pain scores. Data will be collected immediately prior to commencing NIV, the first, second and sixth hours; if NIV support continues over 24 hours, then daily data will be obtained up to five days. Last questionnaire page consists of data for clinical outcome, reason of NIV failure, necessity of re-intubation and if so timing of re-intubation.

Primary outcome of this study is to observe success rates in decreasing necessity of mechanical ventilation or re-intubation. Successfully managed children will also be evaluated for age groups, underlying disease as well as modes of delivery and ventilation parameters to define thresholds on decision of NIV success or failure. Secondary outcome is to evaluate the NIV failure in terms of pediatric age groups, underlying disease, rates of NIV-related complications. If a respiratory failure occurs, modes of delivery and ventilation parameters, usage of different masks, timing of failure decision according to patients' clinical data will be explored from collected data.

Each center will fill in the questionnaire according to patient data and every two months period data will be collected from collaborators. After one year period, statistical evaluation will be investigated by the principle investigators.

Below participants may observe the questionnaire form:

Form - I

1. Age (months):

2. Sex:

3. Weight (kg):

4. PRISM - III score

5. Which one of the following describes the underlying disease? i. What is the acutely-developed illness that required noninvasive ventilation? (Can be marked more than one option)

1. Heart failure

2. Pneumonia

3. Bronchiolitis /Asthma

4. Acute respiratory distress syndrome (ARDS)

5. Sepsis

6. Laryngeal stridor after extubation (or respiratory distress)

7. Other (please describe) :

ii. What is the chronic underlying disease (Primary disease which occurred previously) (can be marked more than one option)

1. Neuromotor disease

2. Metabolic disease

3. Malignancy

4. Congenital cardiac disease

5. Chronic pulmonary disease

6. Immune deficiency

7. Other (please specify)

8. No chronic underlying disease

6. What is the type of respiratory insufficiency?

1. Hypoxemic (Type I)

2. Hypercapnic (Type II)

7. Was the patient intubated before noninvasive ventilation?

1. Yes

2. No

8. If participant's answer is YES to previous question, please describe the length of intubation period (hours):

9. Which one of the following describes NIV device?

1. Specific noninvasive ventilation device

2. Conventional mechanical ventilator with the noninvasive mode

3. High flow nasal cannula

4. BIPAP device (without oxygen blender)

5. Other:

10. Which one of the mask types did participant apply in the patient?

1. Nasal mask

2. Oronasal mask

3. Full face mask

4. Nasal prong (cannula)

5. Endotracheal tube

6. Other (please specify):

Form - II: Variables attached below will be recorded at initial, first, second, sixth, 24th, 48th, 72th, 96th, 120th hours.

• Respiratory rate

• Heart rate

• Systolic tension

• Mean tension

• Diastolic tension

• PRISM - III score

• PELOD score

• Glasgow coma score

• Blood gas (arterial/ venous/ capillary)

• Partial arterial oxygen concentration (PaO2) / Fraction of Inspired oxygen (FiO2)

• Oxygen saturation (SpO2) / Fraction of Inspired oxygen ( FiO2)

• Partial arterial carbon dioxide concentration (PaCO2)

• Power of Hydrogen (pH)

• Device Mode

• Inspiratory positive airway pressure (IPAP) value

• Expiratory positive airway pressure (EPAP) value

• Fraction of inspired oxygen (FiO2) value

• Inspiratory time (IT)

• Rise time value

• Tidal volume

• Leakage (%)

• Mandatory rate

• High flow rate

• Sedo-analgesia drugs and dosage

• Comfort score

Form - III

1. Please select your observation on NIV success.

1. Patient had to be re-intubated after 48 hours of NIV.

2. Patient was successfully withdrawn from NIV in 48 hours.

3. Patient received noninvasive ventilation for ……………………days.

2. If participant's answer is 'A' to the previous question, please specify the reason of re-intubation below (can be marked more than once)

1. Patient - ventilator asynchrony

2. Face - mask mismatch

3. Significant leakage percentage

4. Progress to respiratory failure (can be marked more than once) (i) SpO2/FiO2<193 in 0-1 hour (ii) FiO2 necessity > %80 (iii) Blood gas power of hydrogen (pH) <7.25 in two hours (iv) Failure to achieve 10% expected decrease in respiratory rate at second and sixth hours (v) Increase in clinically observed respiratory effort (vi) Progression to severe ARDS (Oxygenation index > 8)

5. Neurologically deteriorating patient (Glasgow coma score < 8 or deterioration over three units)

6. Risk of aspiration or bulbar dysfunction (loss of swallowing)

7. Hemodynamic instability

8. Arrythmia

9. Pneumothorax

10. Other (please specify):

3. If participant observes a complication in the patient, please specify below (can be marked more than once).

1. Loss of skin intact

2. Pneumothorax

3. Puking and aspiration pneumonia

4. Hemodynamic instability

5. Other (please specify): ……………….................

6. No complication was observed.

4. Please specify the length of noninvasive ventilation ………………………….. (hours)

5. If patient received NIV breaks in a day, please write down the length of ventilation hours per day.

Day 1:……………………………… Day 2: …………………………………...

6. What is clinical outcome of the patient after noninvasive ventilation support?

1. Respiratory failure diminished and patient was discharged from Pediatric intensive care unit (PICU) after ……………. (days / hours) .

2. Patient was discharged form PICU with home- style noninvasive device after …………… days/hours)

3. Patient necessitated tracheostomy.

4. Patient died of respiratory failure after ………………. days/hours.

7. What is the length of hospital discharge? (please specify): ……………………. ;

Related Conditions & MeSH terms

• Failure, Respiratory
• High Flow Nasal Cannula
• Noninvasive Positive Pressure Ventilation
• Respiratory Insufficiency

• NCT number: NCT03066934
• Study type: Observational [Patient Registry]
• Source: Akdeniz University
• Status: Completed
• Start date: November 2016
• Completion date: November 2018